Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies

Area of Science:

• Ophthalmology
• Neuroscience
• Cell Biology

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Retinal ganglion cells (RGCs) are crucial for vision and are progressively lost in glaucoma.
• Identifying RGC death mechanisms is vital for developing effective treatments.

Purpose of the Study:

• To review the cellular and molecular mechanisms underlying RGC apoptosis in glaucoma.
• To discuss the experimental and clinical evidence supporting these mechanisms.
• To outline the rationale for potential neuroprotective strategies.

Main Methods:

• Literature review of experimental and clinical studies.
• Analysis of cellular pathways involved in RGC death.
• Synthesis of evidence for neuroprotective approaches.

Main Results:

• Multiple mechanisms contribute to RGC death, including neurotrophic factor deprivation, ischemia, glial activation, glutamate excitotoxicity, and aberrant immune responses.
• These pathways are interconnected and contribute to the progressive nature of glaucomatous damage.
• Experimental and clinical data support the viability of targeting these mechanisms for neuroprotection.

Conclusions:

• Targeting specific cellular and molecular pathways offers a promising therapeutic avenue for glaucoma.
• A comprehensive understanding of RGC death mechanisms is essential for designing effective neuroprotective treatments.
• Further research into neuroprotective strategies is warranted to prevent vision loss in glaucoma.